FDA Approves First Monoclonal Antibody Treatment for Arthritis in Dogs
MONDAY, May 8, 2023 (HealthDay News) — Man’s aging best friend has a new treatment to dull osteoarthritis pain as the U.S. Food and Drug Administration (FDA) announced approval Friday of the first monoclonal antibody for dogs. Called Librela, the bedinvetmab shot controls pain from the most common form ofContinue Reading